← FDA DRUG APPROVALS

FDA ANDA · ANDA211825

TRAMADOL HYDROCHLORIDE

Sponsor: UNICHEM

APPLICATION
ANDA211825
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-09
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

TRAMADOL HYDROCHLORIDEPrescription
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 22AP
2026-02-13Labeling · Supplement 16 · standardAP
2026-02-13Labeling · Supplement 21 · standardAP
2024-10-31REMS · Supplement 15AP
2023-12-15Labeling · Supplement 14 · standardAP
2023-12-15Labeling · Supplement 13 · standardAP
2023-11-30Labeling · Supplement 12 · standardAP
2023-11-30Labeling · Supplement 5 · standardAP
2023-11-30Labeling · Supplement 8 · standardAP
2020-05-11Labeling · Supplement 2 · standardAP
2019-08-09UNKNOWN · Original · standardREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →